Jimin Choi

Learn More
BACKGROUND A combination of busulfan (Bu) and cyclophosphamide (Cy) has been used as a standard myeloablative regimen for allogeneic hematopoietic stem cell transplantation (HSCT). Recent studies postulate that fludarabine (Flu) is a less toxic substitute for Cy. METHODS Forty-two patients who were diagnosed with acute leukemia or myelodysplastic syndrome(More)
  • 1